Market closedNon-fractional

Stevanato Group/STVN

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Stevanato Group

Stevanato Group SPA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Ticker

STVN

Sector

Healthcare

Trading on

NYSE

Industry

Life Sciences Tools and Services

Headquarters

Piombino Dese, Italy

Employees

5,635

Stevanato Group Metrics

BasicAdvanced
$4.9B
Market cap
32.87
P/E ratio
$0.55
EPS
0.61
Beta
$0.06
Dividend rate
0.32%
Dividend yield
$4.9B
0.61
$0.06
1.925
1.345
21.086
28.319
10.50%
54.61%
5.96%
11.54%
32.87
4.1
3.69
3.93
-16.09
0.32%
7.30%
-5.94%
14.67%
4.39%
-93.88%

What the Analysts think about Stevanato Group

Analyst Ratings

Majority rating from 10 analysts.
Buy

Stevanato Group Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
7.96% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
€236M
-26.39%
Net income
€19M
-58.41%
Profit margin
7.96%
-43.51%

Stevanato Group Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 27.71%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
€0.14
€0.15
€0.18
€0.08
-
Expected
€0.13
€0.15
€0.19
€0.11
€0.10
Surprise
7.59%
-1.64%
-6.68%
-27.71%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

Jul
15
Stevanato Group
Dividend·Payment
€0.053
Per share

FAQs

What’s the current market cap for Stevanato Group stock?

Stevanato Group (STVN) has a market cap of $4.9B as of July 04, 2024.

What is the P/E ratio for Stevanato Group stock?

The price to earnings (P/E) ratio for Stevanato Group (STVN) stock is 32.87 as of July 04, 2024.

Does Stevanato Group stock pay dividends?

Yes, the Stevanato Group (STVN) stock pays dividends to shareholders. As of July 04, 2024, the dividend rate is $0.05694 and the yield is 0.32%. Stevanato Group has a payout ratio of 10.5% on a trailing twelve-month basis.

When is the next Stevanato Group dividend payment date?

The next Stevanato Group (STVN) dividend payment is scheduled for July 15, 2024.

What is the beta indicator for Stevanato Group?

Stevanato Group (STVN) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Stevanato Group stock

Buy or sell Stevanato Group stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing